Physician

Adam D Horvit, M.D.

According to 2025 Medicare claims, Adam Horvit, M.D. (NPI: 1578590105) practices neurology in the Austin-Round Rock-San Marcos, TX market, with the plurality of this provider's patient population coming from Williamson, TX. This provider's primary affiliated billing organization is CENTRAL TEXAS NEUROLOGY CONSULTANTS, PA (NPI: 1790718146; TIN: 742710396) and primary practice location at 78681-3579.

Horvit's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 496 traditional Medicare patients, billed 18,012 HCPCS/CPT codes, and received $1,238,290 in Medicare payments. The top billing code was 95910 (Nerve conduction, 7-8 studies). Part D data shows 2,102 prescription claims across 363 beneficiaries totaling $1,415,268 in drug costs, led by Radicava Ors (Edaravone). DME data shows 55 claims. Open Payments data shows 58 records totaling $37,139. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $343,403 to $1,238,290. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $317,833 to $1,415,268. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $219,104 and ending at $156,279.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	538	9,197	$343,403
2016	541	11,791	$424,473
2017	517	11,471	$375,284
2018	580	18,336	$503,259
2019	603	15,988	$546,530
2020	577	21,416	$1,473,935
2021	567	22,579	$2,064,589
2022	585	23,481	$2,025,974
2023	552	19,856	$1,356,989
2024	496	18,012	$1,238,290

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	238	1,780	$317,833
2016	252	1,819	$197,449
2017	258	1,908	$286,320
2018	269	1,960	$476,860
2019	306	1,978	$1,063,941
2020	285	2,007	$1,810,371
2021	305	1,854	$1,738,304
2022	307	1,887	$2,265,350
2023	308	1,884	$1,728,072
2024	363	2,102	$1,415,268

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	117	$75,440
2016	N/R	51	$31,178
2017	81	266	$159,419
2018	N/R	111	$40,081
2019	N/R	48	$7,217
2020	N/R	N/R	N/R
2021	N/R	42	$30,715
2022	N/R	61	$33,158
2023	N/R	73	$53,681
2024	N/R	55	$34,081

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95910	Nerve conduction, 7-8 studies	50	50	$127
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	69	69	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	326	488	$86
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	104	205	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	65	73	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Radicava Ors	Edaravone	19	532	$266,765
Gabapentin	Gabapentin	466	30,840	$9,538
Rivastigmine	Rivastigmine	45	2,274	$6,854
Tramadol Hcl Er	Tramadol Hcl	25	990	$4,064
Pyridostigmine Bromide	Pyridostigmine Bromide	87	5,300	$3,971

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	29	$29,423
E0482	Cough stimulating device, alternating positive and negative airway pressure	Y	N/R	12	$3,964
K0739	Repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes	N	N/R	14	$694

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	56	$31,758	ARGENX US, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$5,381	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam D. Horvit, M.D.?

Tedicare shows public-source Medicare data for Adam D. Horvit, M.D. (NPI 1578590105), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam D. Horvit, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam D. Horvit, M.D.?

Adam D. Horvit, M.D. is linked to CENTRAL TEXAS NEUROLOGY CONSULTANTS, PA (billing NPI 1790718146) in the available physician profile data.

Does Adam D. Horvit, M.D. have Open Payments data?

Adam D. Horvit, M.D. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.